Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy

Published:2025-01 Issue: Volume:312 Page:122750
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Yazdimamaghani Mostafa^ORCID,Kolupaev Oleg V.,Lim Chaemin,Hwang Duhyeong,Laurie Sonia J.^ORCID,Perou Charles M.^ORCID,Kabanov Alexander V.^ORCID,Serody Jonathan S.^ORCID

Publisher

Elsevier BV

Reference51 articles.

1. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies;Lehmann;The Journal of clinical investigation,2011

2. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis;Chang;Nat. Commun.,2018

3. Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial;Wang;Nat. Commun.,2023

4. Advances in systemic therapies for triple negative breast cancer;Leon-Ferre;Br. Med. J.,2023

5. Targeting a cell surface vitamin D receptor on tumor-associated macrophages in triple-negative breast cancer;Staquicini;Elife,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP